Medtronic plc | Large-cap | Healthcare
$88.75
1.81%
| Medtronic plc Stock Comparison:
Medtronic plc vs Abbott LaboratoriesMedtronic plc vs Boston ScientificMedtronic plc vs StrykerMedtronic plc vs Edwards LifesciencesMedtronic plc vs DexcomMedtronic plc vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 33.5B
Gross Profit 21.9B 65.32%
Operating Income 6.5B 19.50%
Net Income 4.7B 13.99%

Balance Sheet Metrics

Total Assets 90.0B
Total Liabilities 39.6B
Shareholders Equity 50.4B
Debt to Equity 0.78

Cash Flow Metrics

Operating Cash Flow 5.9B
Free Cash Flow 5.2B

Revenue & Profitability Trend

Medtronic plc Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 33.5B 32.4B 31.2B 31.7B 30.1B
Cost of Goods Sold 11.6B 11.2B 10.7B 10.1B 10.5B
Gross Profit 21.9B 21.1B 20.5B 21.5B 19.6B
Research & Development 2.7B 2.7B 2.7B 2.7B 2.5B
Selling, General & Administrative 10.8B 10.7B 10.4B 10.3B 10.1B
Other Operating Expenses 1.8B 2.2B 1.6B 2.6B 2.1B
Total Operating Expenses 15.4B 15.6B 14.7B 15.6B 14.7B
Operating Income 6.5B 5.5B 5.8B 5.9B 4.9B
Pre-tax Income 5.6B 4.8B 5.4B 5.5B 3.9B
Income Tax 936.0M 1.1B 1.6B 456.0M 265.0M
Net Income 4.7B 3.7B 3.8B 5.1B 3.6B
EPS (Diluted) - $2.76 $2.82 $3.73 $2.66

Income Statement Trend

Medtronic plc Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 21.9B 21.7B 23.1B 22.5B 22.0B
Non-Current Assets 68.0B 69.3B 67.9B 70.5B 68.7B
Total Assets 90.0B 90.9B 91.0B 93.1B 90.7B
Liabilities
Current Liabilities 10.8B 9.1B 12.4B 8.5B 10.4B
Non-Current Liabilities 28.8B 30.2B 25.9B 33.0B 29.5B
Total Liabilities 39.6B 39.3B 38.3B 41.5B 39.8B
Equity
Total Shareholders Equity 50.4B 51.7B 52.7B 51.6B 50.9B

Balance Sheet Composition

Medtronic plc Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 3.7B 3.8B 5.1B 3.6B 4.8B
Operating Cash Flow 5.9B 5.2B 6.6B 5.3B 6.8B
Investing Activities
Capital Expenditures -1.6B -1.5B -1.4B -1.4B -1.2B
Investing Cash Flow -2.4B -3.5B -1.7B -2.9B -3.2B
Financing Activities
Dividends Paid -3.7B -3.6B -3.4B -3.1B -2.9B
Financing Cash Flow -4.4B -7.2B -5.3B -7.3B -4.2B
Free Cash Flow 5.2B 4.6B 6.0B 4.9B 6.0B

Cash Flow Trend

Medtronic plc Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.84
Forward P/E 14.71
Price to Book 2.30
Price to Sales 3.29
PEG Ratio 14.71

Profitability Ratios

Profit Margin 13.90%
Operating Margin 17.09%
Return on Equity 9.51%
Return on Assets 4.41%

Financial Health

Current Ratio 1.85
Debt to Equity 61.39
Beta 0.82

Per Share Data

EPS (TTM) $3.61
Book Value per Share $37.46
Revenue per Share $26.09

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
mdt 110.3B 23.84 2.30 9.51% 13.90% 61.39
Abbott Laboratories 231.9B 17.31 4.75 30.65% 31.89% 27.09
Boston Scientific 149.9B 73.94 6.75 9.50% 11.58% 52.16
Stryker 148.0B 52.39 7.07 14.26% 12.31% 82.92
Edwards Lifesciences 43.3B 30.51 4.27 16.51% 75.71% 6.86
Dexcom 31.3B 60.03 13.81 23.72% 12.90% 113.97

Financial data is updated regularly. All figures are in the company's reporting currency.